Pulmonary Hypertension, Interstitial Lung Disease

Cardiovascular·MeSH: Hypertension, Pulmonary

Prevalence

30.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Pulmonary Hypertension, Interstitial Lung Disease?

There are 1 clinical trial targeting Pulmonary Hypertension, Interstitial Lung Disease tracked by BioSniper.

What is the prevalence of Pulmonary Hypertension, Interstitial Lung Disease?

The estimated prevalence of Pulmonary Hypertension, Interstitial Lung Disease is approximately 30.0 per 100,000 population.

Deep-dive into Pulmonary Hypertension, Interstitial Lung Disease

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Pulmonary Hypertension, Interstitial Lung Disease — Drugs in Development & Clinical Trials | BioSniper